Wellbiotech "Subsidiary's PDRN Product 'First Export'"

Wellbiotech subsidiary Wellbiotech PDRN is set to fully launch its PDRN (polydeoxyribonucleotide) business in China, known as a cell regeneration substance.

On the 23rd, Wellbiotech PDRN announced that it has signed an exclusive sales contract in China with the global distribution company ‘Yilaibosheng Gongji Shu (Shenzhen) Co., Ltd.’ (hereinafter referred to as Yilaibosheng Gongji Shu). Yilaibosheng Gongji Shu is a distribution company based in Shenzhen, China, with a capital of 50 million yuan (approximately 10 billion KRW), operating nationwide online and offline sales networks and overseas branches in Hong Kong, the United States, Europe, and other regions.

Wellbiotech PDRN will grant Yilaibosheng Gongji Shu exclusive sales rights in China for its self-produced PDRN raw material ‘Raw-PDRN’ and all processed products developed and sold using it. PDRN-based products include cosmetics, hair growth promoters, products for seniors and people with disabilities, pet health products, and general food items.

Yilaibosheng Gongji Shu will exclusively supply Wellbiotech PDRN’s products within China and promote the development of high-end premium products using the raw material Raw-PDRN.

Opal Lyu, CEO of Yilaibosheng Gongji Shu, stated, “In addition to selling PDRN-based products, we will analyze the key components of Raw-PDRN to develop high-value products,” adding, “We are rushing to launch more than five new products within this year.”

Gu Sehyun, CEO of Wellbiotech PDRN, said, “With this exclusive sales contract, we expect sales not only domestically but also through exports within this year,” and added, “We are currently expanding the production of Raw-PDRN and export products at the Gimje manufacturing plant.”

This content was produced with the assistance of AI translation services.